Open AccessRisk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration
Author(s) -
Alexander R. Ende,
Alireza Sedarat,
Pari Shah,
Nirag Jhala,
Douglas L. Fraker,
Jeffrey A. Drebin,
David C. Metz,
Michael L. Kochman
Publication year - 2016
Publication title -
endoscopic ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.883
H-Index - 24
eISSN - 2303-9027
pISSN - 2226-7190
DOI - 10.4103/2303-9027.175897
Subject(s) - medicine , endoscopic ultrasound , fine needle aspiration , neuroendocrine tumors , radiology , oncology , biopsy
Nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) are increasingly being diagnosed but management, especially of small tumors, remains a clinical dilemma. Endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) is now routinely used for diagnosis of pancreatic neuroendocrine tumors (pNETs) but has not been well studied as a tool for identifying aggressive disease.